ARNT and hepatocellular carcinoma: CUR inhibits HIF-1 in certain HCC cell lines and in vivo studies with tumor xenografts This was shown to occur by CUR inducing the degradation of the aryl hydrocarbon receptor nuclear translocator (ARNT).